Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects

Author(s): Spyridon Siafis, Dimitrios Tzachanis, Myrto Samara, Georgios Papazisis*

Journal Name: Current Neuropharmacology

Volume 16 , Issue 8 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: Antipsychotic-induced metabolic side effects are major concerns in psychopharmacology and clinical psychiatry. Their pathogenetic mechanisms are still not elucidated.

Methods: Herein, we review the impact of neurotransmitters on metabolic regulation, providing insights into antipsychotic-induced metabolic side effects.

Results: Antipsychotic drugs seem to interfere with feeding behaviors and energy balance, processes that control metabolic regulation. Reward and energy balance centers in central nervous system constitute the central level of metabolic regulation. The peripheral level consists of skeletal muscles, the liver, the pancreas, the adipose tissue and neuroendocrine connections. Neurotransmitter receptors have crucial roles in metabolic regulation and they are also targets of antipsychotic drugs. Interaction of antipsychotics with neurotransmitters could have both protective and harmful effects on metabolism.

Conclusion: Emerging evidence suggests that antipsychotics have different liabilities to induce obesity, diabetes and dyslipidemia. However this diversity cannot be explained merely by drugs’pharmacodynamic profiles, highlighting the need for further research.

Keywords: Receptor-binding profiles, antipsychotics, metabolic side effects, neurotransmitters, obesity, diabetes, metabolic regulation, feeding behavior.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 30 June, 2017
Page: [1210 - 1223]
Pages: 14
DOI: 10.2174/1570159X15666170630163616
Price: $65

Article Metrics

PDF: 50